Publication date
Tender published on 28/07/2026.
- Cover page and NIT both state Date of Publication / Tender Date as 28/07/2026.
Loading
Loading…
Loading…
Supply of Real Time PCR on Reagent Rental Basis for contract period of one year for Molecular Pathology Department
MPMMCC Varanasi · Varanasi, Uttar Pradesh2026_TMC_919439_1
Written by TenderKart AI from the documents published when it was generated. Check the tender for later corrigenda before you bid.
28 Jul 2026
18 Aug 2026
₹48,000
All important dates as they stand after corrigenda: publication, pre-bid/clarification deadline, bid submission deadline, bid opening, and bid validity period.
Tender published on 28/07/2026.
Online bid submission closes on 18/08/2026 up to 13:00 Hrs.
Technical bid opens online on 19/08/2026 from 14:30 Hrs.
Tender validity is 180 days.
No pre-bid meeting date or hard clarification cut-off is specified; only contact channels for clarifications are given.
Reagent-rental contract is for one (01) year, plus one (01) year extendable on satisfactory performance, mutual agreement and requirement.
Delivery against supply orders to MPMMCC and HBCH, Varanasi is within 15 days of Order/s (FOR destination).
Tender value or estimated cost, EMD/bid security (amount, acceptable forms, validity), tender document fees, performance security, and key payment terms.
No estimated cost or tender value is stated in the tender documents or BOQ.
EMD is ₹48,000/- (Rupees Forty-Eight Thousand Only).
Tender Processing Fee is Nil.
Security Deposit / Performance Guarantee / performance security is required, but amount, form and deadline are not quantified in the NIT or conditions.
100% payment within 45 days after successful supply by consignee and acceptance by the consignor.
L1 is on consolidated lowest unit value including GST in INR of listed reagents/consumables, or consolidated CPRT (cost per reportable test) including GST; additional/optional items must be comparable.
Every pass/fail eligibility and qualification requirement: experience and past performance, turnover/net worth, registrations and certifications, consortium/JV rules, and debarment or blacklisting conditions.
Bidder must be a legal entity (individual/partners/body corporate) competent technically and financially, with adequate skilled manpower and necessary licenses including import/export capability as applicable.
Evidence of supply of similar nature of items in the last three years to government / reputed private hospitals or reputed organizations in India is required.
No minimum turnover or net-worth threshold is fixed; bidders must submit last 03 years audited P&L and Balance Sheet (with UDIN) and last 03 years ITR.
PAN, GST, bidder-category proof, OEM authorisation (if dealer/agent), product brochure, Make-in-India status, land-border compliance and related certificates are required.
Bidders from countries sharing a land border with India (or with specified ToT from such countries) are restricted unless registered with the Competent Authority; model compliance certificate required.
Make in India classification applies: Class-I local supplier ≥50% local content; Class-II ≥20% and <50%; Non-local <20%. Class-I gets purchase preference (margin 20% in multi-award text).
Notarised affidavit on ₹100 stamp paper must confirm no conviction under relevant laws and no debarment/blacklisting/penalization in the last three years, plus GST/IT up-to-date and lowest-rate affirmation.
No consortium or joint-venture participation rules, equity floors or size caps are specified.
Late bids, short validity, missing EMD, incomplete scope, non-acceptance of special conditions, conditional offers, price in technical bid, and non-compliance with warranty/AMC-CMC/buyback clauses are unresponsive.
What is being procured: the work, supplies or services, deliverables and quantities, locations, phases, completion or delivery timelines, applicable standards, and notable exclusions.
Supply of Real Time PCR (Qty-01) on Reagent Rental Basis with mandatory reagents/consumables for one year for Molecular Pathology at MPMMCC & HBCH, Varanasi.
One Real Time PCR instrument plus tentative 1-year reagent/consumable quantities; quantities are approximate and may vary ± and by actual hospital requirement; award quantity can vary ±25%.
Delivery/installation site is MPMMCC/HBCH, Sundar Bagiya, Near Nariya Gate, Varanasi (U.P.) – 221005; FOR destination; reagents within 15 days of order.
High-end open Real Time PCR (CE-IVD/FDA), EGFR and other oncologic markers, 96-well block, ≥5-plex, branded PC workstation, compatible online UPS with 1 hr backup, IQ/OQ/PQ, calibration/validation during RC, free updates/upgrades, local service support.
Supplier must maintain equipment and bought-out items (including software updates/licenses) through reagent-rental/warranty/CMC with 96% uptime guarantee and spare/consumable support for equipment life.
The complete checklist of documents to submit — mandatory vs conditional, with any prescribed formats, proformas or annexures — plus how to submit: portal and mode, envelope/cover structure, digital signature requirements, signing and attestation rules, and physical originals with their deadline.
E-tender two-part bid on CPPP https://eprocure.gov.in/eprocure/app only; manual/hard-copy financial offers are invalid.
Upload and sign with Class III digital signature of pre-authorised personnel registered on CPPP, obtained from a G.O.I. approved Certifying Authority.
EMD instrument or Purchase Department deposit receipt is to be enclosed in a sealed envelope; NIT refers to a NOTE for details but the NOTE is not printed.
Each page of technical and commercial offers uploaded should be signed and sealed; no overwriting; rubber stamp where asked; NIT to be signed and stamped.
Fill compliance column with data/figures/range in remarks; Yes/No in compliance report and do not quote prices in technical bid.
Every corrigendum/addendum in order — what changed (original vs amended value), its impact, and the action for the bidder — ending with the values that finally apply.
The AI found nothing to report for this question.
Genuine conflicts within and across the documents (original vs corrigenda, clause vs annexure, tender document vs BOQ): both sides with citations, and which value prevails.
Cover page and Tendernotice set submission 18/08/2026 13:00 and opening 19/08/2026 14:30; NIT table on p.3 prints 18/07/2026 and 19/07/2026. August dates prevail as they align with publication on 28/07/2026.
Cover/specs identify Molecular Pathology; NIT narrative on p.3 says Hematopathology Department.
Technical specifications require breakdown resolution within 12 hours; Penalty section Response Time says not more than 24 hours.
NIT p.3 exempts NSIC/SSI/MSME manufacturers and allows Insurance Surety Bonds; p.23 also exempts Startup and repeats Surety Bonds; eligibility p.21 lists only DD/FDR/BG/Banker's Cheque and no Startup in the EMD row.
Serial # G points to wrong serial letters for several formats versus TOC and printed annexures (e.g. Bid Security as #J instead of #I; Tender Acceptance as #K instead of #J; land-border as #O instead of #N; MII as #S instead of #R; affidavit as #P instead of #O; OEM auth as #L instead of #K).
Bid Security Declaration form prints Tender No. HBCH/MPMMCC/ST/29/KH, while the tender is HBCH/MPMMCC/RC/ST/29/KH.
Multiple clauses require Security Deposit/Performance Guarantee and Bid Security Declaration refers to an NIT-defined performance-security deadline, yet NIT never states amount, form or deadline.
NIT EMD cell says 'refer NOTE below for details' about sealed-envelope/Purchase Department deposit, but no such NOTE appears under the NIT table.
Only critical, tender-specific pre-bid queries that could materially change bid/no-bid, pricing, eligibility or contractual risk. Skip generic or obvious questions the documents already answer clearly.
Please confirm whether online submission closes on 18/08/2026 13:00 and technical opening is 19/08/2026 14:30, and that the July dates on NIT p.3 are typographical errors.
Please specify the Security Deposit / Performance Guarantee / performance security percentage or amount, acceptable instruments, validity and submission deadline after LOI/PO.
Please issue the missing NOTE: exact address, addressee, and latest date/time for physical sealed-envelope EMD instrument or Purchase Department deposit receipt.
BOQ and schedule list specific Cobas catalogue numbers (EGFR V2.0, DNA Sample Prep, cfDNA, MWP plate). Confirm whether equivalent CE-IVD/FDA kits from other OEMs on an open system are acceptable, or only Cobas kits on a Cobas-compatible platform.
On reagent-rental basis, confirm whether the Real Time PCR instrument is placed free of cost, who holds title during/after contract, buyback/return obligations, and whether any equipment capital cost may be loaded into reagent CPRT.
Penalty is 0.004%/hour of 'total cost of the equipment (excluding works)' with 96% uptime and 360 hrs/year free downtime. Please confirm how equipment cost is determined under pure reagent rental (no capital BOQ line) and whether reagent stock-outs count as downtime.
Confirm whether the end-user is Molecular Pathology or Hematopathology and whether any additional markers/tests beyond EGFR/cfDNA listed kits are mandatory in year-1 scope.
Commercial, legal and execution risks a bidder should weigh: liquidated damages and penalties, unusual or one-sided clauses, tight timelines, and payment or security risks.
96% uptime with penalty 0.004%/hour (0.1%/day) of total equipment cost; 360 hrs/year free downtime, but stretches beyond 168 hrs count fully; Director may levy penalty irrespective of overall uptime.
Reagent orders must be delivered FOR destination within 15 days; LD 0.5% of delayed portion per week, capped at 10% of delayed goods value.
Replacement of 10% of spare parts in the first year is treated as supply of defective equipment requiring full equipment replacement at Principal/Indian agent cost.
Director may cancel/add/reduce/defer purchase at any stage without compensation (EMD refunded without interest); policy changes before award bind the vendor; institute will not sign vendor-format legal contracts.
Notarised affidavit must affirm quoted rates are lowest and not higher than wholesale/other institutions; disclosure certificate also warrants no lower identical supply in India in last six months.
Vendor bears temporary destruction/reconstruction and any damage during installation at own cost; structural consultant clearance where applicable; shifting/manpower at no cost to institute.
Payment is only after successful supply and acceptance, within 45 days; rejected goods unpaid and removable in two weeks or auctioned at supplier risk.
Mandatory demo of the exact quoted model at bidder cost (global/India/site) after technical opening; failure can reject bid. Physical demo may require bringing equipment to Varanasi within 15 days.
Failure to furnish undefined Security Deposit/Performance Guarantee in 'stipulated time' can forfeit EMD; Bid Security Declaration adds 2-year suspension risk.
The inviting authority and relevant contacts: office, person, designation, address, phone and email — and which address receives physical submissions, if any.
Director, MPMMCC/HBCH Varanasi (Unit of Tata Memorial Centre, DAE, Govt. of India), Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Sundar Bagiya, Near Nariya Gate / Sunderpur, Varanasi (U.P.) – 221005.
Biomedical Department Tel 05422517699 Extn. 1217; Molecular Pathology Dept. MPMMCC Tel 05422517699 Extn. 3307.
DCA, MPMMCC Tel No. 05422517699 Extn. 1123.
Purchase Department Tel 05422517699 Extn. 1131/1132; emails [email protected] and [email protected] (also [email protected] in e-tender instructions).
24x7 CPP helpdesk: 0120-4001 002, 0120-4001 005, 0120-6277 787; technical [email protected]; policy [email protected].